AstraZeneca PLC Long-term Investment Intensity

Latest as of December 2019: 2.5%

AstraZeneca PLC long-term investment intensity. AstraZeneca PLC (ZEGA) has a Long-term Investment Intensity of 2.5% as of December 2019. Long-term investments of €1.51 Billion represent 2.5% of total assets of €61.38 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read ZEGA current and long-term liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

2.5%
LT Investments / Total Assets

Long-term Investments

€1.51 Billion
EUR

Total Assets

€61.38 Billion
EUR

Country

Germany
F

Long-term Investment Intensity of AstraZeneca PLC (2014–2019)

Long-term investment intensity of AstraZeneca PLC from 2014 to 2019. This chart shows how AstraZeneca PLC's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 2.5%, reflecting long-term investments of €1.51 Billion against total assets of €61.38 Billion EUR.

AstraZeneca PLC Long-term Investment Intensity by Year (2014–2019)

AstraZeneca PLC long-term investment intensity by year from 2014 to 2019. The table below presents the year-by-year Long-term Investment Intensity for AstraZeneca PLC from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ZEGA asset base.

Year LT Investment Intensity LT Investments (EUR) Total Assets Change (pp)
2019 2.5% €1.51 Billion €61.38 Billion ▲ +0.9 pp
2018 1.6% €978.00 Million €60.65 Billion ▼ -0.2 pp
2017 1.8% €1.12 Billion €63.35 Billion ▲ +0.3 pp
2016 1.4% €891.00 Million €62.53 Billion ▲ +0.3 pp
2015 1.1% €669.00 Million €60.06 Billion ▼ -0.1 pp
2014 1.2% €722.00 Million €58.59 Billion —
pp = percentage points